Atlas Trials

Phase II Study of Maintenance Capecitabine to Treat Resectable Colorectal Cancer

Clinical trial NCT01880658 · UNKNOWN

Trial details

NCT number
NCT01880658
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Neoplasms
Start date
2013-06-01
Primary completion
2016-05-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.